User: prashantiyengar Topic: IP
Category: drugs :: india
Last updated: Apr 23 2014 19:01 IST RSS 2.0
 
1 to 20 of 2,345    
Pfizer complains about India’s intellectual property regime again (Cached) 23.4.2014 ET: Pharma
In a letter, US pharma giant Pfizer has urged the Indian government to “shift from using destructive IP policy as an access strategy”.
Also found in: [+]
Novartis buys Glaxo’s cancer arm for $16 billion (Cached) 23.4.2014 TOI: Intl Business
Novartis will focus more on cancer, GlaxoSmithKline on vaccines and Eli Lilly & Co on animal health as the drugmakers announced a series of deals for a total of as much as $28.5 billion.
Also found in: [+]
Pfizer, AstraZeneca shares climb up amidst deal talks (Cached) 23.4.2014 ET: Pharma
The two drugmakers declined to confirm the development, even as the news sent market punters to bet on the likely impact on its Indian subsidiaries.
Also found in: [+]
US pharmaceutical giant Pfizer keen to acquire AstraZeneaca for $100 billion (Cached) 22.4.2014 New Kerala: Business India
Washington, Apr 21 : US based pharmaceutical company Pfizer has proposed to take over its British rival AstraZeneca for 60 billion pounds (101 billion dollars).
Also found in: [+]
Indian govt prepares to battle US pressure on trade laws (Cached) 22.4.2014 Rediff: Business
A certain segment of the US pharma industry have become vocal about Indian policies on domestic content requirements and IPR.
Also found in: [+]
Urgent drill to counter US trade threat (Cached) 19.4.2014 Telegraph: Business
New Delhi, April 18: India is getting ready for the mother of all trade spats ' a confrontation with the US, which accounts for trade worth $70 billion annually, over pharma and telecom.
Also found in: [+]
Indian patent and pharma laws should not be considered discriminatory: Public Citizen (Cached) 15.4.2014 ET: Policy
In a submission to US International Trade Commission, 'Public Citizen' said that India's rules meet the data protection requirements.
Also found in: [+]
Natco seeks to block Gilead's hepatitis C drug patent in India: Report (Cached) 10.4.2014 ET: Pharma
Natco Pharma Ltd has formally asked the Indian patent office to deny US drugmaker Gilead Sciences Inc's new hepatitis C drug Sovaldi a patent in India.
Also found in: [+]
Free trade agreements contain provisions that restrict access to medicines: UNITAID (Cached) 5.4.2014 TOI: Intl Business
UNITAID, a global health initiative has warned against bilateral and regional trade agreements, pushed mostly by Europe and the US, as such agreements go well beyond traditional trade concerns and include provisions that force extensive obligations related to intellectual property and investor protection which would restrict access to medicines.
Also found in: [+]
US Patents rejects Teva's plea on Copaxone; Natco shares up (Cached) 5.4.2014 TOI: India Business
The US Patent and Trademark Office has rejected the application of Israel’s Teva Pharmaceutical seeking reissue of patent for its blockbuster multiple sclerosis drug Copaxone.
Also found in: [+]
Drugs giant Biocon rejects Novartis patent accusations (Cached) 4.4.2014 ET: Pharma
Biocon on Friday rejected allegations by Novartis that it infringed on the Swiss pharmaceutical giant's patent for its blockbuster diabetes drug Galvus.
Also found in: [+]
Novartis sues Biocon for patent breach (Cached) 4.4.2014 Rediff: Business
The multinational has filed infringement proceedings and is seeking an injunction against the Indian rival at the Delhi High Court, trying to block the Bangalore-based biotechnology firm from launching a generic version of Galvus, also known as vildagliptin.
Also found in: [+]
Novartis files patent suit against Biocon over Galvus (Cached) 3.4.2014 ET: Pharma
Novartis has taken India's Biocon to court for infringing the patent on its diabetes drug Galvus, the Swiss drugmaker said.
Also found in: [+]
Is India's war against multinational corporations justified? (Cached) 28.3.2014 Rediff: Business
The realisation has struck people that multinationals have been doing all those things that Indian businessmen have long been accused of doing.
Also found in: [+]
Prime Minister Manmohan Singh urged to reject US pressure tactics on trade and business policies (Cached) 28.3.2014 ET: Foreign Trade
The group asked India to call upon the countries which are part of the BRICS to forge a united front against United States' unjustified unilateral measures.
Also found in: [+]
PM urged to reject US pressure tactics on trade, biz policies (Cached) 28.3.2014 Rediff: Business
The unilateral pressure by US administration on India, at the behest of US Business Associations lobby through US International Trade Commission investigations and request to USTR to enlist India under Priority Foreign Country under Special 301 review, lacks legitimacy under WTO framework, the signatories to the letter said.
Also found in: [+]
DIPP rejects proposal for cheaper versions of cancer drug Dasatinib (Cached) 27.3.2014 ET: Pharma
DIPP has shot down a health ministry proposal to consider a government-initiated compulsory licence for cancer drug Dasatinib.
Also found in: [+]
Suven Life secures two product patents for its new chemical entities in US (Cached) 26.3.2014 TOI: India Business
These patents are valid through 2029 and 2030 respectively, the company said.
Also found in: [+]
Diabetes drug may help reduce Alzheimer's spread: Study (Cached) 25.3.2014 New Kerala: World News
Also found in: [+]
Plea against Gilead's patent bid (Cached) 25.3.2014 TOI: India Business
The move by the Delhi Network of Positive People (DNP+) and Initiative for Medicines Access and Knowledge (I-MAK) is the second pre-grant opposition filed on the drug - the first was filed last year at the Kolkata Patent Office.
Also found in: [+]
1 to 20 of 2,345